Pădure L - Search Results

1

Expanding the Clinical Phenotype of 19q Interstitial Deletions: A New Case with 19q13.32-q13.33 Deletion and Short Review of the Literature.

Shelby ES, Morris M, Pădure L, Mirea A, Cocoș R, Cărămizaru A, Șerban-Sosoi S, Pîrvu A, Streață I. Shelby ES, et al. Among authors: padure l. Genes (Basel). 2022 Jan 24;13(2):212. doi: 10.3390/genes13020212. Genes (Basel). 2022. PMID: 35205257 Free PMC article. Review.

2

Extracorporeal shockwave therapy (ESWT) benefits in spastic children with cerebral palsy (CP).

Mirea A, Onose G, Padure L, Rosulescu E. Mirea A, et al. Among authors: padure l. J Med Life. 2014;7 Spec No. 3(Spec Iss 3):127-32. J Med Life. 2014. PMID: 25870710 Free PMC article.

3

New VOUS in CASK Gene Correlating with the MICPCH Phenotype.

Shelby ES, Lupu OT, Axente M, Leanca MC, Badina M, Padure L, Mirea A, Pelttari LM. Shelby ES, et al. Among authors: padure l. Maedica (Bucur). 2021 Mar;16(1):135-139. doi: 10.26574/maedica.2020.16.1.135. Maedica (Bucur). 2021. PMID: 34221169 Free PMC article.

4

Clinical features and genetics in non-5q spinal muscular atrophy caused by acid ceramidase deficiency.

Axente M, Shelby ES, Mirea A, Sporea C, Badina M, Padure L, Ion DA. Axente M, et al. Among authors: padure l. J Med Life. 2021 May-Jun;14(3):424-428. doi: 10.25122/jml-2021-0147. J Med Life. 2021. PMID: 34377212 Free PMC article.

5

Combination Therapy with Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type I.

Mirea A, Shelby ES, Axente M, Badina M, Padure L, Leanca M, Dima V, Sporea C. Mirea A, et al. Among authors: padure l. J Clin Med. 2021 Nov 26;10(23):5540. doi: 10.3390/jcm10235540. J Clin Med. 2021. PMID: 34884240 Free PMC article.

6

Comparative Analysis of the Quality of Life in Families with Children or Adolescents Having Congenital versus Acquired Neuropathology.

Morcov MV, Pădure L, Morcov CG, Mirea A, Ghiță M, Onose G. Morcov MV, et al. Among authors: padure l. Children (Basel). 2022 May 12;9(5):714. doi: 10.3390/children9050714. Children (Basel). 2022. PMID: 35626891 Free PMC article.

7

Physical Therapy and Nusinersen Impact on Spinal Muscular Atrophy Rehabilitative Outcome.

Mirea A, Leanca MC, Onose G, Sporea C, Padure L, Shelby ES, Dima V, Daia C. Mirea A, et al. Among authors: padure l. Front Biosci (Landmark Ed). 2022 Jun 6;27(6):179. doi: 10.31083/j.fbl2706179. Front Biosci (Landmark Ed). 2022. PMID: 35748255 Free article.

8

Clinical and Electrophysiological Changes in Pediatric Spinal Muscular Atrophy after 2 Years of Nusinersen Treatment.

Axente M, Mirea A, Sporea C, Pădure L, Drăgoi CM, Nicolae AC, Ion DA. Axente M, et al. Among authors: padure l. Pharmaceutics. 2022 Sep 29;14(10):2074. doi: 10.3390/pharmaceutics14102074. Pharmaceutics. 2022. PMID: 36297509 Free PMC article.

9

Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy.

Badina M, Bejan GC, Sporea C, Padure L, Mirea A, Leanca MC, Axente M, Grigoras FP, Bejan M, Shelby ES, Neagu E, Ion DA. Badina M, et al. Among authors: padure l. Medicina (Kaunas). 2023 Jul 4;59(7):1244. doi: 10.3390/medicina59071244. Medicina (Kaunas). 2023. PMID: 37512056 Free PMC article.

10

A review of published reports on neuroprotection in spinal cord injury.

Onose G, Anghelescu A, Muresanu DF, Padure L, Haras MA, Chendreanu CO, Onose LV, Mirea A, Ciurea AV, El Masri WS, von Wild KR. Onose G, et al. Among authors: padure l. Spinal Cord. 2009 Oct;47(10):716-26. doi: 10.1038/sc.2009.52. Epub 2009 Jul 14. Spinal Cord. 2009. PMID: 19597522 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page